ChinaOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,221 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 132,085 | 135,239 |
| Total Cites | 16,340 | 18,803 |
| H-index | 65 | 69 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1,237 | 1,446 |
| Number of Single+First+Last Authored Papers | 292 | 292 |
| Total Cites to Single+First+Last Authored Papers | 9,176 | 10,552 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,934 | 13,853 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.36 |
| Self-Citation Percentage |
13.10%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,183 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125,772 | 128,563 |
| Total Cites | 15,322 | 17,738 |
| H-index | 63 | 67 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1,207 | 1,416 |
| Number of Single+First+Last Authored Papers | 289 | 289 |
| Total Cites to Single+First+Last Authored Papers | 8,578 | 9,920 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,063 | 12,960 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.37 |
| Self-Citation Percentage |
13.62%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,167 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121,335 | 122,509 |
| Total Cites | 12,758 | 15,002 |
| H-index | 58 | 62 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1,118 | 1,324 |
| Number of Single+First+Last Authored Papers | 290 | 290 |
| Total Cites to Single+First+Last Authored Papers | 7,044 | 8,278 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,937 | 10,758 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.39 |
| Self-Citation Percentage |
14.96%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 1,117 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 119,000 | 118,918 |
| Total Cites | 10,416 | 12,477 |
| H-index | 51 | 55 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1,025 | 1,229 |
| Number of Single+First+Last Authored Papers | 279 | 279 |
| Total Cites to Single+First+Last Authored Papers | 5,679 | 6,807 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,060 | 8,813 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.42 |
| Self-Citation Percentage |
16.52%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.